Pharmaceutical News

RSS

New computational model helps understand how dopamine medications affect non-motor functions

A new brain-based computational model is helping to understand how Parkinson's disease and dopamine medications-used to treat motor symptoms caused by the disease- can affect learning and attention.

21 Jan 2010

Local physicians are currently recruiting PTSD patients for clinical research study

Researchers are currently recruiting patients with civilian post-traumatic stress disorder (PTSD) for a clinical research study called the COPE study. People who are having symptoms after experiencing a traumatic event or who have been diagnosed with PTSD may be eligible to participate in this study of a new investigational drug.

21 Jan 2010

Health Canada approves Novartis' Afinitor to treat patients with mRCC

Novartis Pharmaceuticals Canada Inc. (Novartis) announced today that Afinitor(R) (everolimus), a once-daily oral cancer treatment, has been approved by Health Canada for patients with metastatic renal cell carcinoma (mRCC), also known as advanced kidney cancer, after failure of initial treatment with VEGF-receptor targeted therapies Sutent(R) (sunitinib) or Nexavar(R) (sorafenib).

20 Jan 2010

Most Americans knowledgeable about heart health, but do not exercise or maintain a healthy diet

A new survey of American adults revealed that while most feel knowledgeable when it comes to heart health, many do not put their knowledge into practice. In fact, 81 percent of respondents reported feeling well-informed about ways to maintain heart health and almost nine out of 10 knew they could help reduce the risk of heart disease by exercising and maintaining a healthy diet.

20 Jan 2010

Novel approach could speed up discovery for new psychiatric drugs

Researchers from the University of British Columbia and Harvard University have co-developed a system that captures on video and barcodes the behavioral responses of zebrafish to chemical compounds on a large scale. The approach could dramatically speed up the discovery of new psychiatric drugs.

20 Jan 2010

Taking opioids long term could hold small risk of addition

Coping with chronic non-cancer pain is a way of life for millions of Americans. Unfortunately, many older adults, in particular, hesitate to take opioids — a kind of narcotic — for fear of addiction. However, a new review finds that taking opioids long term is associated with clinically significant pain relief in some patients with a very small risk of addition.

20 Jan 2010

HPV vaccine will reduce number of cervical cancer cases in women under 30

The number of women under 30 diagnosed with cervical cancer will fall nearly two thirds by 2025, thanks to the HPV vaccine.

20 Jan 2010

AMRI’s Rensselaer labs and manufacturing facilities receive SafeBridge Potent Compound Safety Certification

SAFEBRIDGE® CONSULTANTS, INC., headquartered in Mountain View, California, has announced that AMRI’s high potency research laboratories and GMP-manufacturing facilities in Rensselaer, New York have met the criteria established under the SafeBridge program for “Potent Compound Safety Certification” and have been deemed competent and proficient in the safe handling of potent active pharmaceutical ingredients (“APIs”).

20 Jan 2010

Wound Care Innovations' CellerateRx highlighted at the SuperBones East conference

Wound Management Technologies, Inc., a rapidly growing provider of specialty medical products, announced today that its subsidiary Wound Care Innovations was highlighted as part of a presentation exhibited at the SuperBones East conference in Nassau, Bahamas, on January 14-17. The SuperBones Conference has a great reputation for high quality educational lectures and workshops and places top national speakers at the podium.

20 Jan 2010

Protein supplements do not improve athletes' performance

Protein supplements don't improve performance or recovery time and, according to a recent study, such supplements are inefficient for most athletes. "They are often poorly used or unnecessary by both high-level athletes and amateurs," says Martin Fr-chette, a researcher and graduate of the Universit- de Montr-al Department of Nutrition.

20 Jan 2010

Over 44% of internet Viagra is counterfeit

Research by UK, Swedish and American researchers shows that taking internet drugs can kill and bypassing health systems can leave life-threatening problems undiagnosed. It's estimated that 90% of counterfeit drugs are sold on the internet, 44% of internet Viagra is fake, the global sale of counterfeit drugs will reach $75 billion this year and EU seizures have risen dramatically. Counterfeit drug deaths include men who took fake erectile dysfunction drugs, pregnant women injected with fake iron for anaemia and children who took paracetamol syrup contaminated with antifreeze.

20 Jan 2010

Officials debate merits of medical marijuana as coping tool in pain fight

As access to medical marijuana becomes more widespread, officials are debating its use as a pain-coping treatment and are easing rules for the sick to use the drug, The Wall Street Journal reports. "The U.S. Department of Justice has said it will not generally prosecute ill people under doctors' care whose use of the drug complies with state rules. New Jersey will become the 14th state to allow therapeutic use of marijuana, and the number is likely to grow. Illinois and New York, among others, are considering new laws."

20 Jan 2010

European Patent Office grants a patent for Rexahn Pharmaceuticals' RX-3117

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted a patent for its novel anti-cancer compound, RX-3117.

20 Jan 2010

Endo Pharmaceuticals' partners receive Paragraph IV Certification Notice regarding LIDODERM

Endo Pharmaceuticals announced today that its partners, Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc. have received a Paragraph IV Certification Notice from Watson Laboratories, Inc. advising of the filing of an Abbreviated New Drug Application (ANDA) for a generic version of LIDODERM® (lidocaine topical patch 5%).

20 Jan 2010

U.S. gastroenterologists to treat hepatitis C patients with telaprevir

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that U.S. gastroenterologists will treat a larger proportion of treatment nonresponder hepatitis C patients with Vertex/Tibotec/Mitsubishi Tanabe's telaprevir than Merck's boceprevir.

20 Jan 2010

Sagent Pharmaceuticals introduces pamidronate disodium injection in single-dose vials

Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that it has launched pamidronate disodium injection in single-dose vials containing 30 mg per 10 mL and 90 mg per 10 mL. Pamidronate disodium injection, the generic alternative of Novartis Pharmaceutical Company's Aredia®, is a bone resorption inhibitor. The 2008 U.S. market for pamidronate disodium approximated $17 million, according to IMS data.

20 Jan 2010

LEO Pharma launches psoriasis franchise in the U.S.

Denmark-based LEO Pharma, a global leader in dermatology and critical care, announced its official launch in the U.S. Headquartered in Parsippany, New Jersey, LEO Pharma U.S. will be one of the largest individual operations in the pharmaceutical company’s network of worldwide affiliates and is expected to contribute significantly to the company revenues in 2010.

20 Jan 2010

Media outlets examine efforts to develop malaria vaccines

Scientists have identified a group of proteins they say could form the basis of a malaria vaccine, Australia's ABC News reports. "However, they say more laboratory work and clinical trials need to be done, with a vaccine at least 10 years away," the news service reports (Macey, 1/19).

20 Jan 2010

Antibiotic drops are safe and effective for treating swimmer's ear

When treating the pain and inflammation of swimmer's ear, antibiotic drops are the most effective — and safest - therapy, finds a new review of studies.

20 Jan 2010

Watson Laboratories files ANDA for Lidoderm

Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc., has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market its lidocaine topical patch 8% prior to the expiration of U.S. Patent No. 5,827,529.

19 Jan 2010

Pharmaceutical News

New computational model helps understand how dopamine medications affect non-motor functions

Local physicians are currently recruiting PTSD patients for clinical research study

Health Canada approves Novartis' Afinitor to treat patients with mRCC

Most Americans knowledgeable about heart health, but do not exercise or maintain a healthy diet

Novel approach could speed up discovery for new psychiatric drugs

Taking opioids long term could hold small risk of addition

HPV vaccine will reduce number of cervical cancer cases in women under 30

AMRI’s Rensselaer labs and manufacturing facilities receive SafeBridge Potent Compound Safety Certification

Wound Care Innovations' CellerateRx highlighted at the SuperBones East conference

Protein supplements do not improve athletes' performance

Over 44% of internet Viagra is counterfeit

Officials debate merits of medical marijuana as coping tool in pain fight

European Patent Office grants a patent for Rexahn Pharmaceuticals' RX-3117

Endo Pharmaceuticals' partners receive Paragraph IV Certification Notice regarding LIDODERM

U.S. gastroenterologists to treat hepatitis C patients with telaprevir

Sagent Pharmaceuticals introduces pamidronate disodium injection in single-dose vials

LEO Pharma launches psoriasis franchise in the U.S.

Media outlets examine efforts to develop malaria vaccines

Antibiotic drops are safe and effective for treating swimmer's ear

Watson Laboratories files ANDA for Lidoderm

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News